Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Researchers have discovered a novel approach to protecting insulin-producing beta cells ... this approach would allow doctors to directly target beta cell loss, which could improve long-term ...

Type 1, not type 2 diabetes, is autoimmune. There are other rarer autoimmune types. Learn about type 2 diabetes, immunity, ...

Diets and weight-loss drugs are marketed with health halos. But the real drive to lose weight is the societal stigma around ...

The geroscience hypothesis holds that targeting molecular pathways that drive aging can give us more healthy years. Evidence ...

For patients, this research could lead to new treatments that protect the insulin-producing cells ... would allow doctors to directly target beta cell loss, which could improve long-term disease ...

Inositol supplements show significant benefits for hormonal disorders, insulin sensitivity, and fertility issues, offering a natural approach.

Otherwise known as an artificial pancreas or closed-loop system, an automated insulin delivery (AID) system is a technology ...